On 23rd January 2015 Glycosmedia launched an update of their well established website
The new website and free weekly newsletters utilise new technology to make them more mobile responsive, and all the news items are tagged and categorised for optimal information review https://www.glycosmedia.com/categories-tags/
Glycosmedia has built up a huge archive of links to research papers and other pertinent information that extends back to 2008 https://www.glycosmedia.com/news-archive/
Our service remains free thanks to the generous support of our sponsors and their logos and links can be seen on every page of the website.
Please feel free to comment on the new website by contacting our editor-in-chief Jim Young on firstname.lastname@example.org
Our diabetes news feed is also disseminated via our:
Twitter feed http://twitter.com/Glycosmedia
App for iPhone and iPad http://itunes.com/apps/glycosmedia
Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals
Jim Young editor-in-chief
Launch of a new diabetes news service – Glycosmedia
Essential information on diabetes is now just a click away with the recent and successful launch of a new diabetes news portal called Glycosmedia.
New subscribers from the UK and from the global health community are signing up every day to receive free weekly e-mail newsletters.
Professor Steve Bain (consultant diabetologist)
Doctor Harry Brown (general practitioner)
Doctor Mark Freeman (consultant diabetologist)
Are convinced that the plethora of excellent information on the numerous international diabetes websites is simply too much for the busy professional to visit and assess every day.
Paradoxically they also consider the Internet to be a critical source of information about diabetes information. But thanks to Glycosmedia this conundrum has been solved by the efforts of Jim & Sue Young who are the medical editors of Glycosmedia.
Glycosmedia is not in competition with, or designed to replace the excellent websites that already exist, but it will provide a listing of the most pertinent new articles, research papers and general information that have been published on those websites in the previous few days. Professionals working in the field of diabetes, both in the clinic and in research are pointed straight to the material via a succinct list of hyperlinked headlines and brief introductions. It is anticipated that Glycosmedia will also be of interest to allied professionals involved with, or interested in diabetes, and also to patients wishing to keep abreast of latest developments.
The most important point to note is that the material listed on Glycosmedia is selected “by hand” and is not the result of an imprecise automated electronic trawl of the Internet. Only the most pertinent information is presented to the busy professional. Although the service is based in the UK it has a global outlook.
As well as being available online Glycosmedia offers a free subscription e-mail service that will deliver a listing of the most pertinent news directly to a subscriber’s Inbox every day.
Finally, although Glycosmedia is actively seeking sponsorship to support this service it is, and will always remain, a free and an editorially independent resource. There will never be any commercial input into our editorial material which is selected purely on its merit.